Action Alert: Voluntary Withdrawal of IVIG Product

Action Alert
As part of HFA’s ongoing mission to assist and advocate for the bleeding disorders community, this action alert is being issued to keep you informed about blood safety.
About This Withdrawal
Due to increased reports of hypersensitivity reactions such as rashes or urticaria and/or wheezing, Octapharma USA Inc. has voluntarily withdrawn from the market one lot of IVIG medication Octagam 5% [Immune Globulin Intravenous (human)] Liquid Prep therapy.
Who does this withdrawal impact?
This voluntary withdrawal impacts patients currently using Octagam 5% [Immune Globulin Intravenous (human)] Liquid Prep therapy treatment.
Steps Those Impacted Should Take: 
1.    Check all Octagam 5% labels for Lot K551A44.
2.    Do not infuse with product from this lot.
3.    Return affected product to the point of purchase to receive replacement product.

More About this Recall

Where This Alert Came From
This post is not intended to make any medical claim. This withdrawal announcement was issued by Octapharma USA, Inc., and an alert was sent by Stericycle, Inc., managers of the Patient Notification System (PNS).
The PNS alerts registrants within 24 hours of a product recall or withdrawal. All manufacturers that currently have clotting factor products on the market are participating in this vital notification system reaching registered community members, physicians, nurses, and pharmacies.

This system is fast, free, and confidential.

About the Patient Notification System
Currently, fewer than 8,000 patients are enrolled in the PNS system (that’s less than 40% of the bleeding disorders community)!  Are you signed up?


The PNS is designed to alert patients within 24 hours of recalls that include:

  • Defective sterile water vials
  • Improperly packaged alcohol wipes
  • Problems with the product potency and shelf life
  • Mislabeled products
  • Factor contamination
  • And many more

Sign Up For PNS

If you have medical questions regarding this withdrawal, contact your physician. For clinical questions about Octagam 5%, contact Dipen Patel, Head of US Drug Safety Unit at (202) 604-1137.
For assistance regarding this recall, please call Stericycle, Inc., manager of the Patient Notification System, at 1-888-UPDATE-U (888-873-2838).